Lung carcinoma in African Americans

被引:39
作者
Abidoye, Oyewale
Ferguson, Mark K.
Salgia, Ravi
机构
[1] Univ Chicago, Med Ctr,Dept Med, Pritzker Sch Med, Hematol Oncol Sect, Chicago, IL 60637 USA
[2] Univ Chicago, Sect Cardiothorac Surg, Dept Surg, Med Ctr, Chicago, IL 60637 USA
来源
NATURE CLINICAL PRACTICE ONCOLOGY | 2007年 / 4卷 / 02期
关键词
African American; gene susceptibility; socioeconomic; tailored therapy; tobacco exposure;
D O I
10.1038/ncponc0718
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung carcinoma is the most commonly diagnosed cancer and the leading cause of cancer deaths in the US. It accounts for 12% of all cancers diagnosed worldwide, making it the most common malignancy, other than nonmelanoma skin cancer. A new focus has emerged involving the role of race and ethnicity in lung carcinoma. Current health statistics data demonstrate striking disparities, which are most evident between African American patients and their white counterparts. This disparity is greatest among male patients, where statistically significant differences are seen not only in lung cancer incidence and risk, but also in survival and treatment outcomes. Several hypotheses that attempt to explain this disparity include genetic, cultural and socioeconomic differences, in addition to differences in tobacco use and exposure. Current evidence does not clearly identify the reasons for this observed disparity, or the role the aforementioned factors play in the development and overall outcomes of people with lung cancer in these populations. This disease continues to pose a considerable public health burden and more research is needed to improve understanding of the disparity of lung carcinoma statistics among African Americans. This review summarizes the existing body of knowledge regarding lung carcinoma in African Americans and attempts to identify promising areas for future investigation and intervention.
引用
收藏
页码:118 / 129
页数:12
相关论文
共 79 条
[1]   Enrollment of African Americans onto clinical treatment trials: Study design barriers [J].
Adams-Campbell, LL ;
Ahaghotu, C ;
Gaskins, M ;
Dawkins, FW ;
Smoot, D ;
Polk, OD ;
Gooding, R ;
Dewitty, RL .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (04) :730-734
[2]   Menthol pharmacology and its potential impact on cigarette smoking behavior [J].
Ahijevych, K ;
Garrett, BE .
NICOTINE & TOBACCO RESEARCH, 2004, 6 :S17-S28
[3]   Epidemiology of lung cancer: Looking to the future [J].
Alberg, AJ ;
Brock, MV ;
Samet, JM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (14) :3175-3185
[4]  
ALBERTI W, 1995, BRIT MED J, V311, P899
[5]   Racial differences in the treatment of early-stage lung cancer [J].
Bach, PB ;
Cramer, LD ;
Warren, JL ;
Begg, CB .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (16) :1198-1205
[6]   Primary care physicians who treat blacks and whites [J].
Bach, PB ;
Pham, HH ;
Schrag, D ;
Tate, RC ;
Hargraves, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (06) :575-584
[7]   Similar outcomes between African American and non-African American patients with extensive-stage small-cell lung carcinoma: Report from the Cancer and Leukemia Group B [J].
Blackstock, AW ;
Herndon, JE ;
Paskett, ED ;
Miller, AA ;
Lathan, C ;
Niell, HB ;
Socinski, MA ;
Vokes, EE ;
Green, MR .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (03) :407-412
[8]   Outcomes among African-American/Non-African-American patients with advanced non-small-cell lung carcinoma: Report from the cancer and leukemia group B [J].
Blackstock, AW ;
Herndon, JE ;
Paskett, ED ;
Perry, MC ;
Graziano, SL ;
Muscato, JJ ;
Kosty, MP ;
Akerley, WL ;
Holland, J ;
Fleishman, S ;
Green, MR .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (04) :284-290
[9]   Lung cancer and race: Equal treatment yields equal outcome among equal patients, but there is no equal treatment [J].
Brawley, OW .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (03) :332-333
[10]   Menthol cigarettes and risk of lung cancer [J].
Brooks, DR ;
Palmer, JR ;
Strom, BL ;
Rosenberg, L .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 158 (07) :609-616